Search Results

Filter
  • 1-10 of  2,881 results for ""Factor Xa""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Four-factor prothrombin complex concentrate plus andexanet alfa for reversal of factor Xa inhibitor-associated bleeding: Case series.

  • Authors : Liu J; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Elsamadisi P

Subjects: Factor Xa*/Factor Xa*/Factor Xa*/therapeutic use ; Thromboembolism*/Thromboembolism*/Thromboembolism*/chemically induced ; Thromboembolism*/Thromboembolism*/Thromboembolism*/drug therapy

  • Source: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2022 Aug 05; Vol. 79 (16), pp. Publisher: Oxford University Press Country of Publication: England NLM ID: 9503023 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Andexanet Alfa for Reversing Factor Xa Inhibition.

  • Authors : Sible AM; From the Department of Pharmacy Practice and Administrative Sciences, College of Pharmacy, University of New Mexico, Albuquerque, New Mexico.; Nawarskas JJ

Subjects: Factor Xa/Factor Xa/Factor Xa/*drug effects ; Hemorrhage/Hemorrhage/Hemorrhage/*prevention & control ; Recombinant Proteins/Recombinant Proteins/Recombinant Proteins/*administration & dosage

  • Source: Cardiology in review [Cardiol Rev] 2019 Mar/Apr; Vol. 27 (2), pp. 108-111.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9304686 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Perioperative management of anticoagulation.

  • Authors : Talari G; Division of Hospital Medicine, Henry Ford Hospital , Detroit, Michigan, USA.; Demertzis ZD

Subjects: Practice Guidelines as Topic*; Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*therapeutic use ; Anticoagulants/Anticoagulants/Anticoagulants/*therapeutic use

  • Source: Hospital practice (1995) [Hosp Pract (1995)] 2020 Dec; Vol. 48 (5), pp. 231-240. Date of Electronic Publication: 2020 Jul 13.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101268948 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Anti-factor Xa activity of enoxaparin administered at prophylactic dosage to patients over 75 years old.

Subjects: Anticoagulants/Anticoagulants/Anticoagulants/*therapeutic use ; Blood Coagulation Factor Inhibitors/Blood Coagulation Factor Inhibitors/Blood Coagulation Factor Inhibitors/*metabolism ; Enoxaparin/Enoxaparin/Enoxaparin/*therapeutic use

  • Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2007 Oct; Vol. 64 (4), pp. 428-38. Date of Electronic Publication: 2007 May 17.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Print ISSN:

Record details

×
Academic Journal

[The determination of activity of low-molecular heparins against activated factor Xa by means of the diagnostic kit "Reachrom-Heparin" (scientific-production association "Renam")].

Subjects: Reagent Kits, Diagnostic*; Factor Xa/Factor Xa/Factor Xa/*analysis ; Heparin/Heparin/Heparin/*blood

  • Source: Patologicheskaia fiziologiia i eksperimental'naia terapiia [Patol Fiziol Eksp Ter] 2006 Apr-Jun (2), pp. 16-8.Publisher: Izdatelstvo Meditsina Country of Publication: Russia (Federation) NLM ID: 0376421 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

Non-therapeutic anti-FXa levels are common among medical ward patients treated with enoxaparin.

  • Authors : Saliba W; Medicine Department C, Ha'emek Medical Center, Afula, Israel. ; Nitzan O

Subjects: Autoantibodies/Autoantibodies/Autoantibodies/*blood ; Enoxaparin/Enoxaparin/Enoxaparin/*therapeutic use ; Factor Xa/Factor Xa/Factor Xa/*immunology

  • Source: Annals of hematology [Ann Hematol] 2011 Nov; Vol. 90 (11), pp. 1345-51. Date of Electronic Publication: 2011 Mar 16.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Heparin resistance as detected with an antifactor Xa assay is not more common in venous thromboembolism than in other thromboembolic conditions.

  • Authors : Rosborough TK; Medical Education Department, Abbott Northwestern Hospital, Minneapolis, Minnesota 55407, USA. ; Shepherd ME

Subjects: Drug Resistance*; Anticoagulants/Anticoagulants/Anticoagulants/*administration & dosage ; Drug Monitoring/Drug Monitoring/Drug Monitoring/*methods

  • Source: Pharmacotherapy [Pharmacotherapy] 2003 Feb; Vol. 23 (2), pp. 142-6.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8111305 Publication Model: Print Cited Medium: Print ISSN: 0277-0008

Record details

×
Academic Journal

A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.

  • Authors : Levine MN; Department of Medicine, McMaster University, Hamilton, Ontario.; Hirsh J

Subjects: Partial Thromboplastin Time*; Factor Xa/Factor Xa/Factor Xa/*analysis ; Heparin/Heparin/Heparin/*therapeutic use

  • Source: Archives of internal medicine [Arch Intern Med] 1994 Jan 10; Vol. 154 (1), pp. 49-56.Publisher: American Medical Assn Country of Publication: United States NLM ID: 0372440 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

[A simple test for the monitoring of plasma anti-XA activity of patients following subcutaneous administration of enoxaparin].

Subjects: Factor Xa/Factor Xa/Factor Xa/*analysis ; Heparin, Low-Molecular-Weight/Heparin, Low-Molecular-Weight/Heparin, Low-Molecular-Weight/*therapeutic use ; Thromboembolism/Thromboembolism/Thromboembolism/*prevention & control

  • Source: Wiener klinische Wochenschrift [Wien Klin Wochenschr] 1990 Jul 13; Vol. 102 (14), pp. 408-13.Publisher: Springer Country of Publication: Austria NLM ID: 21620870R Publication Model: Print Cited Medium: Print ISSN: 0043-5325 (Print)

Record details

×
Academic Journal

[Preventive effect of liquemin depot in thromboembolism; experimental proof with myotoxin thrombokinase test].

Subjects: Anticoagulants* ; Crotalid Venoms* ; Factor Xa*

  • Source: Schweizerische medizinische Wochenschrift [Schweiz Med Wochenschr] 1956 Jan 28; Vol. 86 (4), pp. 104-6.Publisher: EMH Swiss Medical Publishers Country of Publication: Switzerland NLM ID: 0404401 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
  • 1-10 of  2,881 results for ""Factor Xa""